3rd Quarter - Report

CHIESI USA, INC. for CHIESI USA, INC.

Firm
Client
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to Therapies for Rare Diseases - no specific legislation. General healthcare access and innovation matters, and regulatory pathway topics - no specific legislation. Implementation of the Joe Fiandra Access to Home Infusion Act of 2025 (Public Law 119-21), including CMS rulemaking and home infusion therapy reimbursement issues.

Foreign entity interest: Chiesi Farmaceutici is interested in all issues on line 16.

LobbyistCovered position, as disclosed
GENTRY LASSITER —
GINA CIOFFI LOUD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.